| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |